Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir study

被引:6
作者
O'Connor, Antoinette [1 ,2 ]
Cash, David M. [1 ]
Poole, Teresa [1 ,3 ]
Markiewicz, Pawel J. [4 ]
Fraser, Maggie R. [1 ]
Malone, Ian B. [1 ]
Jiao, Jieqing [4 ]
Weston, Philip S. J. [1 ]
Flores, Shaney [5 ]
Hornbeck, Russ [5 ]
McDade, Eric [6 ]
Schoell, Michael [1 ,7 ]
Gordon, Brian A. [5 ]
Bateman, Randall J. [6 ]
Benzinger, Tammie L. S. [5 ]
Fox, Nick C. [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England
[2] UK Dementia Res Inst UCL, London, England
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[4] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, London, England
[5] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[6] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[7] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
基金
美国国家卫生研究院; 加拿大健康研究院; 英国医学研究理事会;
关键词
POSITRON-EMISSION-TOMOGRAPHY; PET PATTERNS; F-18-AV-1451; DEPOSITION; PHENOTYPE; TAUOPATHY; TRACER; BRAIN; ONSET;
D O I
10.1186/s13195-023-01234-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cortical tau accumulation is a key pathological event that partly defines Alzheimer's disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in vivo is needed. Data from 59 participants involved in two longitudinal cohort studies of autosomal dominant AD (ADAD) were used to investigate whether tau PET can detect and track presymptomatic change; seven participants were symptomatic, and 52 were asymptomatic but at a 50% risk of carrying a pathogenic mutation. All had baseline flortaucipir (FTP) PET, MRI and clinical assessments; 26 individuals had more than one FTP PET scan. Standardised uptake value ratios (SUVRs) in prespecified regions of interest (ROIs) were obtained using inferior cerebellar grey matter as the reference region. We compared the changes in FTP SUVRs between presymptomatic carriers, symptomatic carriers and non-carriers, adjusting for age, sex and study site. We also investigated the relationship between regional FTP SUVRs and estimated years to/from symptom onset (EYO). Compared to both non-carriers and presymptomatic carriers, FTP SUVRs were significantly higher in symptomatic carriers in all ROIs tested (p < 0.001). There were no significant regional differences between presymptomatic carriers and non-carriers in FTP SUVRs, or their rates of change (p > 0.05), although increased FTP signal uptake was seen posteriorly in some individuals around the time of expected symptom onset. When we examined the relationship of FTP SUVR with respect to EYO, the earliest significant regional difference between mutation carriers and non-carriers was detected within the precuneus prior to estimated symptom onset in some cases. This study supports preliminary studies suggesting that presymptomatic tau tracer uptake is rare in ADAD. In cases where early uptake was seen, there was often a predilection for posterior regions (the precuneus and post-cingulate) as opposed to the medial temporal lobe, highlighting the importance of examining in vivo tau uptake beyond the confines of traditional Braak staging.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Microscopy assessment of a fluorescence [18F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions
    Gatto, Rodolfo G.
    Hossam, Youssef
    Reichard, R. Ross
    Lowe, Val J.
    Whitwell, Jennifer L.
    Josephs, Keith A.
    ALZHEIMERS & DEMENTIA, 2024, : 8758 - 8768
  • [42] Epileptic seizures in autosomal dominant forms of Alzheimer's disease
    Cortini, Francesca
    Cantoni, Claudia
    Villa, Chiara
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 61 : 4 - 7
  • [43] Seizures as an early symptom of autosomal dominant Alzheimer's disease
    Voeglein, Jonathan
    Noachtar, Soheyl
    McDade, Eric
    Quaid, Kimberly A.
    Salloway, Stephen
    Ghetti, Bernardino
    Noble, James
    Berman, Sarah
    Chhatwal, Jasmeer
    Mori, Hiroshi
    Fox, Nick
    Allegri, Ricardo
    Masters, Colin L.
    Buckles, Virginia
    Ringman, John M.
    Rossor, Martin
    Schofield, Peter R.
    Sperling, Reisa
    Jucker, Mathias
    Laske, Christoph
    Paumier, Katrina
    Morris, John C.
    Bateman, Randall J.
    Levin, Johannes
    Danek, Adrian
    NEUROBIOLOGY OF AGING, 2019, 76 : 18 - 23
  • [44] Plasma biomarker profiles in autosomal dominant Alzheimer's disease
    Johansson, Charlotte
    Thordardottir, Steinunn
    Laffita-Mesa, Jose
    Rodriguez-Vieitez, Elena
    Zetterberg, Henrik
    Blennow, Kaj
    Graff, Caroline
    BRAIN, 2023, 146 (03) : 1132 - 1140
  • [45] Modeling autosomal dominant Alzheimer's disease with machine learning
    Luckett, Patrick H.
    McCullough, Austin
    Gordon, Brian A.
    Strain, Jeremy
    Flores, Shaney
    Dincer, Aylin
    McCarthy, John
    Kuffner, Todd
    Stern, Ari
    Meeker, Karin L.
    Berman, Sarah B.
    Chhatwal, Jasmeer P.
    Cruchaga, Carlos
    Fagan, Anne M.
    Farlow, Martin R.
    Fox, Nick C.
    Jucker, Mathias
    Levin, Johannes
    Masters, Colin L.
    Mori, Hiroshi
    Noble, James M.
    Salloway, Stephen
    Schofield, Peter R.
    Brickman, Adam M.
    Brooks, William S.
    Cash, David M.
    Fulham, Michael J.
    Ghetti, Bernardino
    Jack, Clifford R., Jr.
    Voeglein, Jonathan
    Klunk, William
    Koeppe, Robert
    Oh, Hwamee
    Su, Yi
    Weiner, Michael
    Wang, Qing
    Swisher, Laura
    Marcus, Dan
    Koudelis, Deborah
    Joseph-Mathurin, Nelly
    Cash, Lisa
    Hornbeck, Russ
    Xiong, Chengjie
    Perrin, Richard J.
    Karch, Celeste M.
    Hassenstab, Jason
    McDade, Eric
    Morris, John C.
    Benzinger, Tammie L. S.
    Bateman, Randall J.
    ALZHEIMERS & DEMENTIA, 2021, 17 (06) : 1005 - 1016
  • [46] Discovery and validation of autosomal dominant Alzheimer's disease mutations
    Hsu, Simon
    Gordon, Brian A.
    Hornbeck, Russ
    Norton, Joanne B.
    Levitch, Denise
    Louden, Adia
    Ziegemeier, Ellen
    Laforce, Robert, Jr.
    Chhatwal, Jasmeer
    Day, Gregory S.
    McDade, Eric
    Morris, John C.
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Goate, Alison M.
    Cruchaga, Carlos
    Bateman, Randall J.
    Karch, Celeste M.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [47] Longitudinal tau PET in ageing and Alzheimer's disease
    Jack, Clifford R., Jr.
    Wiste, Heather J.
    Schwarz, Christopher G.
    Lowe, Val J.
    Senjem, Matthew L.
    Vemuri, Prashanthi
    Weigand, Stephen D.
    Therneau, Terry M.
    Knopman, Dave S.
    Gunter, Jeffrey L.
    Jones, David T.
    Graff-Radford, Jonathan
    Kantarci, Kejal
    Roberts, Rosebud O.
    Mielke, Michelle M.
    Machulda, Mary M.
    Petersen, Ronald C.
    BRAIN, 2018, 141 : 1517 - 1528
  • [48] Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism
    Lu, Jiaying
    Bao, Weiqi
    Li, Ming
    Li, Ling
    Zhang, Zhengwei
    Alberts, Ian
    Brendel, Matthias
    Cumming, Paul
    Lu, Huimeng
    Xiao, Zhenxu
    Zuo, Chuantao
    Guan, Yihui
    Zhao, Qianhua
    Rominger, Axel
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [49] Tau PET Imaging With [18F]MK-6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease
    Gerard, Thomas
    Colmant, Lise
    Malotaux, Vincent
    Salman, Yasmine
    Huyghe, Lara
    Quenon, Lisa
    Boyer, Emilien
    Dricot, Laurence
    Ivanoiu, Adrian
    Lhommel, Renaud
    Hanseeuw, Bernard
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (02)
  • [50] Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease
    Tetzloff, Katerina A.
    Graff-Radford, Jonathan
    Martin, Peter R.
    Tosakulwong, Nirubol
    Machulda, Mary M.
    Duffy, Joseph R.
    Clark, Heather M.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (04) : 1713 - 1724